Latest News about Johnson & Johnson
Recent news which mentions Johnson & Johnson
From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
   
  
  March 13, 2024
  From CNBC.com News
 
   Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
   
  
  February 13, 2024
  From CNBC.com News
 
   Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
   
  
  February 08, 2024
  From CNBC.com News
 From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  January 29, 2024
  From CNBC.com News
 
   Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
   
  
  January 28, 2024
  From CNBC.com News
 
   Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
   
  
  January 26, 2024
  From CNBC.com News
 
   The U.S. has no federal bereavement leave. What to know about options at work when someone you love dies
   
  
  January 26, 2024
  From CNBC.com News
 
   Treasury yields fall ahead of economic growth numbers
   
  
  January 25, 2024
  From CNBC.com News
 From CNBC.com News
 
   Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
   
  
  January 23, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Tuesday
   
  
  January 23, 2024
  From CNBC.com News
 
   Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
   
  
  January 23, 2024
  From CNBC.com News
 
   Treasury yields fractionally higher ahead of key data releases
   
  
  January 23, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Monday
   
  
  January 22, 2024
  From CNBC.com News
 
   Treasury yields retreat ahead of big week for economic data
   
  
  January 22, 2024
  From CNBC.com News
 From CNBC.com News
 
   Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
   
  
  January 14, 2024
  From CNBC.com News
 
   Jim Cramer compares NFL playoffs teams to stock picks
   
  
  January 12, 2024
  From CNBC.com News
 
   J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
   
  
  January 08, 2024
  From CNBC.com News
 
   Jim Cramer examines the Dow's best and worst performers of 2023
   
  
  January 02, 2024
  From CNBC.com News
 
   Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive
   
  
  December 28, 2023
  From CNBC.com News
 
   Biden administration's Medicare drug price negotiations will face major tests in 2024
   
  
  December 28, 2023
  From CNBC.com News
 
   10-year Treasury yield falls slightly on shorter trading day
   
  
  December 22, 2023
  From CNBC.com News
 
   10-year Treasury yield falls as investors continue to assess path ahead for rate cuts
   
  
  December 21, 2023
  From CNBC.com News
 
   Treasury yields dip slightly as Fed trajectory remains in focus
   
  
  December 20, 2023
  From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
